REQUEST A DEMO
Total
USD $0.00
Search more companies

4 Medicine Rek sp. k. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Periodical Publishers | Book Publishers | Internet Publishing and Broadcasting and Web Search Portals | Computer Systems Design and Related Services | Administrative Management and General Management Consulting Services | Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Social Sciences and Humanities | All Other Professional, Scientific, and Technical Services | Convention and Trade Show Organizers
Full name: 4 Medicine Rek sp. k. Profile Updated: April 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

4 Medicine Rek sp. k is a company that specializes in research analytics systems, optimization algorithms, and science management advice. They offer IT solutions and conduct non-interventional clinical research for pharmaceutical sector companies, academic entities, and research institutions. Their main business activities include providing research and development solutions and introducing innovative technologies for non-interventional research.

Headquarters
Ul. Aleje Jerozolimskie 125/127/601B
Warsaw; Mazowieckie; Postal Code: 02-017

Contact Details: Purchase the 4 Medicine Rek sp. k. report to view the information.

Website: http://www.4medicine.pl

Basic Information
Total Employees:
Purchase the 4 Medicine Rek sp. k. report to view the information.
Outstanding Shares:
Purchase the 4 Medicine Rek sp. k. report to view the information.
Incorporation Date:
June 21, 2011
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after 4 Medicine Rek sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-33.98%
Total operating revenue
-33.99%
Operating profit (EBIT)
-91.71%
Net Profit (Loss) for the Period
-78.33%
Total assets
-3.65%
Total equity
-3.88%
Operating Profit Margin (ROS)
-29.04%
Net Profit Margin
-8.53%
Return on Equity (ROE)
-3.84%
Quick Ratio
-5.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?